TY - CHAP
T1 - Idiopathic Orbital Inflammation
AU - Mombaerts, Ilse
AU - Saeed, Peerooz
AU - Kalmann, Rachel
N1 - Publisher Copyright:
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Idiopathic orbital inflammation (IOI) is a poorly understood orbital disorder characterised by a soft tissue mass or enlarged structure featuring nonspecific orbital inflammation of unknown origin. Most commonly the lacrimal gland, extraocular muscles, or orbital fat are affected, but multiple structures can be involved. IOI constitutes a diagnostic challenge for the lack of robust distinguishing clinical and imaging features. In a clinicoradiological context suggesting IOI, lesions of the lacrimal gland and orbital fat require biopsy to histologically confirm compatibility with IOI and exclude other disorders, while idiopathic orbital myositis may be diagnosed based on corticosteroid responsiveness. Treatment is tailored to affected structures, severity of symptoms and progress of disease, and includes surgical debulking, non-steroidal anti-inflammatory drugs, corticosteroids, radiation therapy, other immunomodulating drugs and biological agents.
AB - Idiopathic orbital inflammation (IOI) is a poorly understood orbital disorder characterised by a soft tissue mass or enlarged structure featuring nonspecific orbital inflammation of unknown origin. Most commonly the lacrimal gland, extraocular muscles, or orbital fat are affected, but multiple structures can be involved. IOI constitutes a diagnostic challenge for the lack of robust distinguishing clinical and imaging features. In a clinicoradiological context suggesting IOI, lesions of the lacrimal gland and orbital fat require biopsy to histologically confirm compatibility with IOI and exclude other disorders, while idiopathic orbital myositis may be diagnosed based on corticosteroid responsiveness. Treatment is tailored to affected structures, severity of symptoms and progress of disease, and includes surgical debulking, non-steroidal anti-inflammatory drugs, corticosteroids, radiation therapy, other immunomodulating drugs and biological agents.
UR - https://www.scopus.com/pages/publications/85206026439
U2 - 10.1007/978-3-031-39638-0_17
DO - 10.1007/978-3-031-39638-0_17
M3 - Chapter
SN - 9783031396373
VL - 2
T3 - Oculoplastic, Lacrimal and Orbital Surgery: the ESOPRS Textbook: Volume 2
SP - 219
EP - 229
BT - Oculoplastic, Lacrimal and Orbital Surgery
PB - Springer Nature
ER -